Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexxar and EBRT in relapsed follicular lymphoma
NCT00475332Phase 2Terminated
- Sponsor
- University of Florida
- Start
- Sep 2007
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of tositumomab in follicular lymphoma (FL), sponsored by University of Florida. Started Sep 2007; status: terminated.
02
Drugs
tositumomab
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT00475332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00475332.